Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

Patient and Physician Preferences for Potentially Resectable, Non-metastatic Non-small Cell Lung Cancer Treatments

The purpose of this study is to investigate the perspectives and preferences of patients and healthcare professionals (medical oncologists, pneumologists, thoracic surgeons) regarding treatment options in the resectable non-small cell lung cancer (NSCLC) setting

Inclusion Criteria:

Patients

• Aged ≥18 years at the time of enrollment in the study
• Resident of the US, Germany, or Japan
• Able to read, speak, and understand English, German or Japanese
• Diagnosed with resectable phase II to IIIB non-small cell lung cancer (NSCLC)

Physicians

• Resident of the US, Germany, or Japan
• Lung cancer-treating physician specialized in one of the following medical areas: oncology, pneumonology, thoracic surgery, or radiology
• Treated at least three new patients with resectable NSCLC in the past year

Exclusion Criteria:

Patients

• Appears to have sensory and/or cognitive impairment(s) that could interfere with their ability to provide online and/or verbal consent, or complete any other interview activities (based on screener judgment)
• Being diagnosed with another malignancy alongside NSCLC
• Not willing to be audio-recorded during the interview

Physicians

• Appears to have sensory and/or cognitive impairment(s) that could interfere with their ability to provide online and/or verbal consent, or complete any other interview activities (based on screener judgment)
• Not willing to be audio-recorded during the interview